ArticleDiabetes, obesity & metabolism2018
Sodium-glucose co-transporter-2 inhibitors and cardiovascular outcome studies in people with type 2 diabetes: From efficacy to effectiveness.
Kamlesh Khunti et al.PubMed ↗Publisher ↗
No numbers read from the abstract.